Corcept Therapeutics Incorporated
CORT
$69.12
-$1.34-1.90%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
4/10/2025
-
MarketBeat
5/8/2025
-
MarketBeat
5/8/2025
-
Ticker Report
5/8/2025
-
StockStory Articles
5/7/2025
-
MarketBeat
5/7/2025
-
ETF Channel
5/7/2025
-
Yahoo! Finance: News
5/7/2025
-
Ticker Report
5/7/2025
-
TipRanks Financial Blog
5/6/2025
-
Simply Wall St
5/6/2025
-
Zacks Investment Research
5/6/2025
-
GuruFocus
5/6/2025
-
TipRanks Financial Blog
5/6/2025
-
The Fly
5/6/2025
-
GuruFocus
5/6/2025
-
GuruFocus
5/6/2025
-
GuruFocus
5/6/2025
-
GuruFocus
5/6/2025
-
GuruFocus
5/6/2025
-
Stocktwits News Feed
5/6/2025
-
GuruFocus
5/6/2025
-
SeekingAlpha
5/6/2025
-
Seeking Alpha: Transcripts
5/5/2025
-
Zacks Investment Research
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Monday, May 5, 2025
Period Date
Monday, March 31, 2025
Next Filing
End of July (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
650 327 3270
Address
101 Redwood Shores Parkway
Redwood City, CA 94065
Redwood City, CA 94065
Country
Year Founded
Business Description
Sector
Corcept Therapeutics Incorporated engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United...
more